Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 N Academy Ave
Danville, PA 17822Phone+1 570-271-7383Fax+1 570-271-7384
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1980 - 1983
OhioHealth/Riverside Methodist HospitalResidency, Internal Medicine, 1977 - 1980
Ohio State University College of MedicineClass of 1977
Certifications & Licensure
PA State Medical License 2016 - 2024
OH State Medical License 1977 - 2019
MN State Medical License 1980 - 1983- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Join now to see all
Publications & Presentations
PubMed
- Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics.Mellar P Davis, Nada Bader, James Basting, Erin Vanenkevort, Nicole Koppenhaver
Journal of Pain and Symptom Management. 2025-02-01 - Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study.Mellar P Davis, Angela Ulrich, Rebecca Segal, Vinay Gudena, Kathryn J Ruddy
Cancers. 2024-12-20 - Respiratory Depression Associated with Opioids: A Narrative Review.Mellar P Davis, Sandra DiScala, Amy Davis
Current Treatment Options in Oncology. 2024-11-01
Press Mentions
Groundbreaking Cannabis Cancer Trial Highlights Ongoing ChallengesSeptember 19th, 2024- Low-Dose Erlotinib Seems Feasible for Frail, Elderly Patients with NSCLCMay 26th, 2020
- Cancer Cachexia: Definitions, Outcomes, and TreatmentsDecember 17th, 2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
